143 related articles for article (PubMed ID: 34218999)
1. Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No.
Macbeth F; Hughes-Davies L
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):749-750. PubMed ID: 34218999
[No Abstract] [Full Text] [Related]
2. Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy?
Ostler P; Hoskin P; Martin A
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):747-748. PubMed ID: 34642067
[No Abstract] [Full Text] [Related]
3. In Response to: 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?' by Ostler et al. and 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No' by Macbeth and Hughes-Davies.
Phillips I; Olson R; Palma D; Harrow S
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e169-e170. PubMed ID: 35148914
[No Abstract] [Full Text] [Related]
4. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.
Jingu K; Matsushita H; Yamamoto T; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Kadoya N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794936. PubMed ID: 30145943
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy for oligometastases.
Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases.
Lodeweges JE; Klinkenberg TJ; Ubbels JF; Groen HJM; Langendijk JA; Widder J
J Thorac Oncol; 2017 Sep; 12(9):1442-1445. PubMed ID: 28576747
[TBL] [Abstract][Full Text] [Related]
8. The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence.
Nicosia L; Mazzola R; Alongi F
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e320-e321. PubMed ID: 35504798
[No Abstract] [Full Text] [Related]
9. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
10. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion-positive lung cancer patient.
Weber B; Liu M; Sobkin P; Morris SW; Hout D; van der Westhuizen N; Tonseth RP; Saltman DL
J Med Radiat Sci; 2016 Mar; 63(1):67-70. PubMed ID: 27087977
[TBL] [Abstract][Full Text] [Related]
12. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.
Yamashita H; Niibe Y; Yamamoto T; Katsui K; Jingu K; Kanazawa S; Terahara A; Nakagawa K
Jpn J Clin Oncol; 2016 Jul; 46(7):687-91. PubMed ID: 27162324
[TBL] [Abstract][Full Text] [Related]
13. A new era of thoracic oncology? Ex-vivo stereotactic ablative radiosurgery within Ex-vivo Lung Treatment System as a hybrid therapy for unresectable locally advanced pulmonary malignancies.
Henkenberens C; Zinne N; Biancosino C; Höffler K; Schmitto JD; Bremer M; Haverich A; Krüger M
Med Hypotheses; 2016 Jul; 92():31-4. PubMed ID: 27241251
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
15. [Role of stereotactic radiotherapy in the treatment of oligometastatic colorectal cancer].
Pouypoudat C; Trouette R; Bernard B; Vendrely V
Cancer Radiother; 2021 Oct; 25(6-7):523-525. PubMed ID: 34454836
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
17. Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?
Stanford-Edwards C; Edwards M; Selby A; Lewis R; Powell C; Nicholas O
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):e105-e106. PubMed ID: 34895991
[No Abstract] [Full Text] [Related]
18. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
Riesterer O
Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
[TBL] [Abstract][Full Text] [Related]
19. Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer.
Filippi AR; Guerrera F; Badellino S; Ceccarelli M; Castiglione A; Guarneri A; Spadi R; Racca P; Ciccone G; Ricardi U; Ruffini E
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):505-12. PubMed ID: 26899780
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
